{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:44:03Z","timestamp":1779925443577,"version":"3.53.1"},"reference-count":33,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A12677, C1479\/A2884"],"award-info":[{"award-number":["A12677, C1479\/A2884"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA152990, 5 U01 CA200462-02"],"award-info":[{"award-number":["CA152990, 5 U01 CA200462-02"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MD Anderson Ovarian SPORE","award":["P50 CA83639, P50 CA217685"],"award-info":[{"award-number":["P50 CA83639, P50 CA217685"]}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention Research Institute of Texas","doi-asserted-by":"publisher","award":["RP101382, RP160145"],"award-info":[{"award-number":["RP101382, RP160145"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["074-02-2018-330"],"award-info":[{"award-number":["074-02-2018-330"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR_UU_12023, G9901012, G0801228, MR\/R02524X\/1"],"award-info":[{"award-number":["MR_UU_12023, G9901012, G0801228, MR\/R02524X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Longitudinal CA125 algorithms are the current basis of ovarian cancer screening. We report on longitudinal algorithms incorporating multiple markers. In the multimodal arm of United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), 50,640 postmenopausal women underwent annual screening using a serum CA125 longitudinal algorithm. Women (cases) with invasive tubo-ovarian cancer (WHO 2014) following outcome review with stored annual serum samples donated in the 5 years preceding diagnosis were matched 1:1 to controls (no invasive tubo-ovarian cancer) in terms of the number of annual samples and age at randomisation. Blinded samples were assayed for serum human epididymis protein 4 (HE4), CA72-4 and anti-TP53 autoantibodies. Multimarker method of mean trends (MMT) longitudinal algorithms were developed using the assay results and trial CA125 values on the training set and evaluated in the blinded validation set. The study set comprised of 1363 (2\u20135 per woman) serial samples from 179 cases and 181 controls. In the validation set, area under the curve (AUC) and sensitivity of longitudinal CA125-MMT algorithm were 0.911 (0.871\u20130.952) and 90.5% (82.5\u201398.6%). None of the longitudinal multi-marker algorithms (CA125-HE4, CA125-HE4-CA72-4, CA125-HE4-CA72-4-anti-TP53) performed better or improved on lead-time. Our population study suggests that longitudinal HE4, CA72-4, anti-TP53 autoantibodies adds little value to longitudinal serum CA125 as a first-line test in ovarian cancer screening of postmenopausal women.<\/jats:p>","DOI":"10.3390\/cancers12071931","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T06:38:55Z","timestamp":1595313535000},"page":"1931","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women"],"prefix":"10.3390","volume":"12","author":[{"given":"Aleksandra","family":"Gentry-Maharaj","sequence":"first","affiliation":[{"name":"MRC Clinical Trials Unit at UCL, Institute of Clinical Trials &amp; Methodology, London WC1V 6LJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0194-6389","authenticated-orcid":false,"given":"Oleg","family":"Blyuss","sequence":"additional","affiliation":[{"name":"School of Physics, Astronomy and Mathematics, University of Hertfordshire, Hatfield AL10 9AB, UK"},{"name":"Department of Paediatrics and Paediatric Infectious Diseases, Sechenov First Moscow State Medical University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Ryan","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit at UCL, Institute of Clinical Trials &amp; Methodology, London WC1V 6LJ, UK"},{"name":"Department of Women\u2019s Cancer, Institute for Women\u2019s Health, University College London, London WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Burnell","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit at UCL, Institute of Clinical Trials &amp; Methodology, London WC1V 6LJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Karpinskyj","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit at UCL, Institute of Clinical Trials &amp; Methodology, London WC1V 6LJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8745-4915","authenticated-orcid":false,"given":"Richard","family":"Gunu","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s Cancer, Institute for Women\u2019s Health, University College London, London WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatinderpal K.","family":"Kalsi","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s Cancer, Institute for Women\u2019s Health, University College London, London WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dawnay","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry, Barts Health NHS Trust, London E1 8PR, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0152-0174","authenticated-orcid":false,"given":"Ines P.","family":"Marino","sequence":"additional","affiliation":[{"name":"Department of Biology and Geology, Physics and Inorganic Chemistry, Universidad Rey Juan Carlos, 28933 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3381-5057","authenticated-orcid":false,"given":"Ranjit","family":"Manchanda","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit at UCL, Institute of Clinical Trials &amp; Methodology, London WC1V 6LJ, UK"},{"name":"Wolfson Institute of Preventive Medicine, Barts CRUK Cancer Centre, Queen Mary University of London, London EC1M 6BQ, UK"},{"name":"Department of Gynaecological Oncology, St Bartholomew\u2019s Hospital, Barts Health NHS Trust, London EC1A 7BE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lu","sequence":"additional","affiliation":[{"name":"University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lei","family":"Yang","sequence":"additional","affiliation":[{"name":"University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-835X","authenticated-orcid":false,"given":"John F.","family":"Timms","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s Cancer, Institute for Women\u2019s Health, University College London, London WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Parmar","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit at UCL, Institute of Clinical Trials &amp; Methodology, London WC1V 6LJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Skates","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4621-8462","authenticated-orcid":false,"suffix":"Jr.","given":"Robert C.","family":"Bast","sequence":"additional","affiliation":[{"name":"University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s Cancer, Institute for Women\u2019s Health, University College London, London WC1E 6BT, UK"},{"name":"Department of Women\u2019s Health, University of New South Wales, Sydney 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Zaikin","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Paediatric Infectious Diseases, Sechenov First Moscow State Medical University, Moscow 119991, Russia"},{"name":"Department of Women\u2019s Cancer, Institute for Women\u2019s Health, University College London, London WC1E 6BT, UK"},{"name":"Department of Applied Mathematics, Lobachevsky University of Nyzhniy Novgorod, Nizhniy Novgorod 603105, Russia"},{"name":"Department of Mathematics, University College London, London WC1H 0AY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-1732","authenticated-orcid":false,"given":"Usha","family":"Menon","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit at UCL, Institute of Clinical Trials &amp; Methodology, London WC1V 6LJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"ref_1","unstructured":"CRUK (2019, January 08). Ten Most Common Causes of Cancer Death in Females. Available online: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/mortality\/common-cancers-compared#heading-Two."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/AOG.0b013e318238d030","article-title":"Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening","volume":"118","author":"Miller","year":"2011","journal-title":"Obs. Gynecol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1525-1438.2007.01035.x","article-title":"A randomized study of screening for ovarian cancer: A multicenter study in Japan","volume":"18","author":"Kobayashi","year":"2008","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet (Lond. Engl.)"},{"key":"ref_6","unstructured":"CRUK (2018, December 12). Ovarian Cancer Survival by Stage at Diagnosis. Available online: http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\/survival#heading-Three."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1002\/cncr.28183","article-title":"A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value","volume":"119","author":"Lu","year":"2013","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1200\/JCO.2005.01.6642","article-title":"Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer","volume":"23","author":"Menon","year":"2005","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1200\/JCO.2004.03.091","article-title":"Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions","volume":"22","author":"Skates","year":"2004","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1198\/016214501753168145","article-title":"Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal Markers","volume":"96","author":"Skates","year":"2001","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.2014.59.4945","article-title":"Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening","volume":"33","author":"Menon","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2012.43.6691","article-title":"Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule","volume":"31","author":"Drescher","year":"2013","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biostatistics\/4.1.27","article-title":"A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker","volume":"4","author":"McIntosh","year":"2003","journal-title":"Biostatistics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"22717","DOI":"10.18632\/oncotarget.25216","article-title":"Parenclitic networks for predicting ovarian cancer","volume":"9","author":"Whitwell","year":"2018","journal-title":"Oncotarget"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bspc.2018.07.001","article-title":"A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer","volume":"46","author":"Blyuss","year":"2018","journal-title":"Biomed. Signal Process. Control"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-18-0208","article-title":"Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population","volume":"24","author":"Blyuss","year":"2018","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41416-019-0718-9","article-title":"Improved early detection of ovarian cancer using longitudinal multimarker models","volume":"122","author":"Whitwell","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/1940-6207.CAPR-18-0377","article-title":"Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer","volume":"12","author":"Simmons","year":"2019","journal-title":"Cancer Prev. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1158\/1078-0432.CCR-17-0284","article-title":"Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer","volume":"23","author":"Yang","year":"2017","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/1940-6207.CAPR-10-0195","article-title":"Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens","volume":"4","author":"Cramer","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jnci\/djp438","article-title":"Assessing lead time of selected ovarian cancer biomarkers: A nested case-control study","volume":"102","author":"Anderson","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/bjc.2017.199","article-title":"A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours","volume":"117","author":"Russell","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","article-title":"Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: Standards for study design","volume":"100","author":"Pepe","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_24","unstructured":"Kurman, R.J., Carcangiu, M.L., Herrington, S., and Young, R.H. (2014). WHO Classification of Tumours of Female Reproductive Organs (IARC WHO Classification of Tumours), IARC. [4th ed.]."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Simmons, A., Fourkala, E.O., Gentry-Maharaj, A., Ryan, A., Baggerly, K.A., Zheng, H., Lu, K.H., Jacobs, I., Skates, S.J., and Menon, U. (2019). Validation of longitudinal performance of a multi-marker panel for the early detection of ovarian cancer. Cancer Prev. Res., in press.","DOI":"10.1158\/1940-6207.CAPR-18-0377"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bspc.2016.11.015","article-title":"Change-point of multiple biomarkers in women with ovarian cancer","volume":"33","author":"Blyuss","year":"2017","journal-title":"Biomed. Signal Process. Control"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11431","DOI":"10.3390\/s150511431","article-title":"A Colorimetric Enzyme-Linked Immunosorbent Assay (ELISA) Detection Platform for a Point-of-Care Dengue Detection System on a Lab-on-Compact-Disc","volume":"15","author":"Thiha","year":"2015","journal-title":"Sensors"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"349.e1","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"a2079","DOI":"10.1136\/bmj.a2079","article-title":"Recruitment to multicentre trials--lessons from UKCTOCS: Descriptive study","volume":"337","author":"Menon","year":"2008","journal-title":"BMJ"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"681416","DOI":"10.1155\/2015\/681416","article-title":"Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset","volume":"2015","author":"Blyuss","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_33","first-page":"19","article-title":"Regression standard errors in clustered samples","volume":"13","author":"Rogers","year":"1993","journal-title":"Stata Tech. Bull."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/7\/1931\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:49:15Z","timestamp":1760176155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/7\/1931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["cancers12071931"],"URL":"https:\/\/doi.org\/10.3390\/cancers12071931","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]}}}